|
PBC | Abstract Library |
 |
|
The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
1. | Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? |
|
Hepatology. 2023 Jul 3. doi: 10.1097/HEP.0000000000000529. Online ahead of print.
Christophe Corpechot 1, Sara Lemoinne 1, Pierre-Antoine Soret 1, Bettina Hansen 2 3, Gideon Hirschfield 3, Aliya Gulamhusein 3, Aldo J Montano-Loza 4, Ellina Lytvyak 5, Albert Pares 6, Ignasi Olivas 6, John E Eaton 7, Karim T Osman 7, Christoph Schramm 8, Marcial Sebode 8, Ansgar W Lohse 8, George Dalekos 9, Nikolaos Gatselis 9, Frederik Nevens 10, Nora Cazzagon 11, Alessandra Zago 11, Francesco Paolo Russo 11, Annarosa Floreani 11, Nadir Abbas 12, Palak Trivedi 13, Douglas Thorburn 14, Francesca Saffioti 14, Laszlo Barkai 14, Davide Roccarina 14, Vicenza Calvaruso 15, Anna Fichera 15, Adèle Delamarre 16, Natalia Sobenko 17, Alejandra Maria Villamil 17, Esli Medina-Morales 18, Alan Bonder 18, Vilas Patwardhan 18, Cristina Rigamonti 19, Marco Carbone 20, Pietro Invernizzi 20, Laura Cristoferi 20, Adriaan van der Meer 21, Rozanne de Veer 21, Ehud Zigmond 22, Eyal Yehezkel 22, Andreas E Kremer 23, Ansgar Deibel 23, Tony Bruns 24, Karsten Große 24, Aaron Wetten 25, Jessica Katharine Dyson 25, David Jones 25, Jérôme Dumortier 26, Georges-Philippe Pageaux 27, Victor de Lédinghen 16, Olivier Chazouillères 1, Fabrice Carrat 28; Global & ERN Rare-Liver PBC Study Groups
|
|
|
2. | Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis |
|
Am J Gastroenterol. 2023 Jul 1;118(7):1196-1203. doi: 10.14309/ajg.0000000000002128.Epub 2022 Dec 14.
Rozanne C de Veer 1, Maria C van Hooff 1, Christophe Corpechot 2, Douglas Thorburn 3, Pietro Invernizzi 4 5, Willem J Lammers 1, Harry L A Janssen 1 6, Pier M Battezzati 7, Frederik Nevens 8, Keith D Lindor 8 9 10, Annarosa Floreani 11 12, Cyriel Y Ponsioen 13, Marlyn J Mayo 14, Albert Parés 15, Andrew L Mason 16, Kris V Kowdley 17, Palak J Trivedi 18, Gideon M Hirschfield 6 18, Jorn C Goet 1, Tony Bruns 19 20, George N Dalekos 21 22, Nikolaos K Gatselis 21 22, Xavier Verhelst 23, Bettina E Hansen 1 6, Maren H Harms 1, Adriaan J van der Meer 1; Global PBC Study Group
|
|
|
3. | Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years |
|
Eur J Gastroenterol Hepatol. 2023 Aug 1;35(8):899-906.doi: 10.1097/MEG.0000000000002582. Epub 2023 Jun 6.
Cristina Rigamonti 1, Carla De Benedittis 1, Sara Labanca 2, Ester Vanni 3, Anna Morgando 3, Giulia Francesca Manfredi 1, Danila Azzolina 4, Micol Giulia Cittone 1, Edoardo Giovanni Giannini 2, Giorgio Maria Saracco 3, Mario Pirisi 1
|
|
|
|
|
|
|
6. | GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus |
|
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1902-1912.e13.doi: 10.1016/j.cgh.2022.10.032. Epub 2022 Nov 4.
Cynthia Levy 1, Stuart Kendrick 2, Christopher L Bowlus 3, Atsushi Tanaka 4, David Jones 5, Andreas E Kremer 6, Marlyn J Mayo 7, Nazneen Haque 2, Robyn von Maltzahn 8, Matthew Allinder 9, Brandon Swift 10, Megan M McLaughlin 9, Gideon M Hirschfield 11; GLIMMER Study Group
|
|
|
|
|
|
|
|
|
|
|
11. | ACR Appropriateness Criteria® Right Upper Quadrant Pain: 2022 Update |
|
J Am Coll Radiol. 2023 May;20(5S):S211-S223.doi: 10.1016/j.jacr.2023.02.011.
Expert Panel on Gastrointestinal Imaging; Gregory K Russo 1, Atif Zaheer 2, Ihab R Kamel 3, Kristin K Porter 4, Krystal Archer-Arroyo 5, Mustafa R Bashir 6, Brooks D Cash 7, Alice Fung 8, Marion McCrary 9, Brendan M McGuire 10, Richard D Shih 11, John Stowers 12, Kiran H Thakrar 13, Abhinav Vij 14, Shaun A Wahab 15, Katherine Zukotynski 16, Laura R Carucci 17
|
|
|
12. | The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis |
|
Hepatol Commun. 2023 Mar 24;7(4):e0068. doi: 10.1097/HC9.0000000000000068.eCollection 2023 Apr 1.
Lars Bossen 1, Tobias Stemann Lau 1, Mette Bak Nielsen 2, Marlene Christina Nielsen 3, Astrid Højmark Andersen 1, Peter Ott 1, Sabine Becker 4, Henning Glerup 4, Lise Svenningsen 5, Martin Eivindson 5, Linda Kornerup 1 6, Niels Bjørndal Kjeldsen 7, Anders Neumann 8, Holger Jon Møller 3, Peter Jepsen 1, Henning Grønbæk 1
|
|
|
13. | Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival |
|
Liver Int. 2023 May 8. doi: 10.1111/liv.15592. Online ahead of print.
C Fiorella Murillo Perez 1, Stephanie Ioannou 2, Iman Hassanally 3, Palak J Trivedi 4, Christophe Corpechot 5, Adriaan J van der Meer 6, Willem J Lammers 6, Pier Maria Battezzati 7, Keith D Lindor 8, Frederik Nevens 9, Kris V Kowdley 10, Tony Bruns 11, Nora Cazzagon 12, Annarosa Floreani 12 13, Andrew L Mason 14, Aliya Gulamhusein 1, Cyriel Y Ponsioen 15, Marco Carbone 16, Ana Lleo 17, Marlyn J Mayo 18, George N Dalekos 19, Nikolaos K Gatselis 19, Douglas Thorburn 20, Xavier Verhelst 21, Albert Parés 22, Maria-Carlota Londoño 22, Harry L A Janssen 1 6, Pietro Invernizzi 16, Raj Vuppalanchi 23, Gideon M Hirschfield 1, Bettina E Hansen 1 3 6, Cynthia Levy 2; Global PBC Study Group
|
|
|
|
|
15. | Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells |
|
Hepatol Commun. 2023 Apr 4;7(4):e0110. doi: 10.1097/HC9.0000000000000110.eCollection 2023 Apr 1.
Victoria Mulcahy 1 2, Evaggelia Liaskou 3 4, Jose-Ezequiel Martin 1 5, Prasanti Kotagiri 6 7, Jonathan Badrock 1, Rebecca L Jones 8, Simon M Rushbrook 9, Stephen D Ryder 10, Douglas Thorburn 11, Simon D Taylor-Robinson 12, Graeme Clark 13, Heather J Cordell 14, Richard N Sandford 1, David E Jones 15 16, Gideon M Hirschfield 17, George F Mells 1 2
|
|
|
|
|
|
|
18. | Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis |
|
Dig Dis Sci. 2023 Feb;68(2):514-520. doi: 10.1007/s10620-022-07654-x.Epub 2022 Aug 22.
Guilherme Grossi Lopes Cançado 1 2, Cláudia Alves Couto 3, Debora Raquel Benedita Terrabuio 4, Eduardo Luiz Rachid Cançado 4, Cristiane Alves Villela-Nogueira 5, Maria Lucia Gomes Ferraz 6, Michelle Harriz Braga 4, Mateus Jorge Nardelli 3, Luciana Costa Faria 3, Nathalia Mota de Faria Gomes 6, Elze Maria Gomes Oliveira 7, Vivian Rotman 5, Maria Beatriz Oliveira 8, Simone Muniz Carvalho Fernandes da Cunha 9, Marlone Cunha-Silva 10, Liliana Sampaio Costa Mendes 11, Claudia Alexandra Pontes Ivantes 12, Liana Codes 9 13, Valéria Ferreira de Almeida E Borges 14 15, Fabio Heleno de Lima Pace 16, Mario Guimarães Pessoa 4, Laura Vilar Guedes 4, Izabelle Venturini Signorelli 17, Gabriela Perdomo Coral 18, Cynthia Levy 19, Paulo Lisboa Bittencourt 13 20; Members of the Brazilian Cholestasis Study Group Consortium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32. | The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight |
|
Dig Liver Dis. 2022 Dec 31;S1590-8658(22)00833-7. doi: 10.1016/j.dld.2022.12.009.Online ahead of print.
Valentina Cossiga 1, Nora Cazzagon 2, Roberto Montalti 3, Stefania Ciminnisi 4, Maria Rosaria Attanasio 5, Francesco Pezzato 6, Marco Giacchetto 4, Maria Guarino 5, Vincenza Calvaruso 4, Annarosa Floreani 7, Filomena Morisco 5
|
|
|
33. | Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls |
|
Gastroenterology. 2022 Dec;163(6):1630-1642.e3.doi: 10.1053/j.gastro.2022.08.054. Epub 2022 Sep 20.
C Fiorella Murillo Perez 1, Holly Fisher 2, Shaun Hiu 2, Dorcas Kareithi 2, Femi Adekunle 3, Tracy Mayne 3, Elizabeth Malecha 3, Erik Ness 3, Adriaan J van der Meer 4, Willem J Lammers 4, Palak J Trivedi 5, Pier Maria Battezzati 6, Frederik Nevens 7, Kris V Kowdley 8, Tony Bruns 9, Nora Cazzagon 10, Annarosa Floreani 10, Andrew L Mason 11, Albert Parés 12, Maria-Carlota Londoño 12, Pietro Invernizzi 13, Marco Carbone 14, Ana Lleo 15, Marlyn J Mayo 16, George N Dalekos 17, Nikolaos K Gatselis 17, Douglas Thorburn 18, Xavier Verhelst 19, Aliya Gulamhusein 1, Harry L A Janssen 20, Rachel Smith 21, Steve Flack 22, Victoria Mulcahy 22, Michael Trauner 23, Christopher L Bowlus 24, Keith D Lindor 25, Christophe Corpechot 26, David Jones 2, George Mells 27, Gideon M Hirschfield 1, James Wason 28, Bettina E Hansen 29; GLOBAL PBC Study Group and the members of the UK-PBC Consortium
Collaborators
- GLOBAL PBC Study Group and the members of the UK-PBC Consortium:
Richard Sturgess, Christopher Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James Maggs, Mohamed Yousif, George Mells, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, George Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash Gupta, David Jones, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook, Robert Przemioslo, Andrew Millar, Steven Mitchell, Andrew Davis, Asifabbas Naqvi, Tom Lee, Stephen Ryder, Jane Collier, Matthew Cramp, Richard Aspinal, Jonathan Booth, Earl Williams, Hyder Hussaini, John Christie, Tehreem Chaudhry, Douglas Thorburn, Stephen Mann, Aftab Ala, Julia Maltby, Chris Corbett, Saket Singhal, Barbara Hoeroldt, Jeff Butterworth, Andrew Douglas, Rohit Sinha, Simon Panter, Jeremy Shearman, Gary Bray, Michael Roberts, Daniel Forton, Nicola Taylor, Wisam Jafar, Matthew Cowan, Chin Lye Ch'ng, Mesbah Rahman, Emma Wesley, Sanjiv Jain, Aditya Mandal, Mark Wright, Palak Trivedi, Fiona Gordon, Esther Unitt, Andrew Austin, Altaf Palegwala, Vishwaraj Vemala, Andrew Higham, Jocelyn Fraser, Andy Li, Subramaniam Ramakrishnan, Alistair King, Simon Whalley, Ian Gee, Richard Keld, Helen Fellows, James Gotto, Charles Millson
|
|
|
34. | Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis? |
|
Can J Gastroenterol Hepatol. 2022 Dec 6;2022:3618090. doi: 10.1155/2022/3618090.eCollection 2022.
Aaron Wetten 1 2, Laura Ogle 1 2, George Mells 3, Vinod S Hegade 4, Laura Jopson 1 2, Margaret Corrigan 5, Jeremy Palmer 1, Maja Johansson 6, Torbjörn Bäckström 6 7, Magnus Doverskog 6, David E J Jones 1 2, Jessica K Dyson 1 2
|
|
|
|
|
|
|
|
|
|
|
39. | Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis |
|
JHEP Rep. 2022 Jul 21;4(11):100544. doi: 10.1016/j.jhepr.2022.100544. eCollection 2022 Nov.
Christoph Schramm 1 2 3, Heiner Wedemeyer 4, Andrew Mason 5, Gideon M Hirschfield 6, Cynthia Levy 7, Kris V Kowdley 8, Piotr Milkiewicz 9 10, Ewa Janczewska 11 12, Elena Sergeevna Malova 13, Johanne Sanni 14 15, Phillip Koo 16, Jin Chen 16, Subhajit Choudhury 17, Lloyd B Klickstein 18, Michael K Badman 18, David Jones 19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46. | TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation |
|
J Hepatol. 2022 Oct;77(4):991-1004. doi: 10.1016/j.jhep.2022.05.044. Epub 2022 Jun 22.
Ibone Labiano 1, Aloña Agirre-Lizaso 1, Paula Olaizola 1, Anne Echebarria 1, Maider Huici-Izagirre 1, Irene Olaizola 1, Aitor Esparza-Baquer 1, Omar Sharif 2, Elizabeth Hijona 3, Piotr Milkiewicz 4, Malgorzata Milkiewicz 5, Francisco González-Romero 6, Patricia Aspichueta 7, Maria J Monte 8, Jose J G Marin 8, Mihael Vucur 9, Tom Luedde 9, Marco Marzioni 10, Derek A Mann 11, Luis Bujanda 12, Pedro M Rodrigues 13, Jesus M Banales 14, Maria J Perugorria 15
|
|
|
|
|
|
|
|
|
|
|
51. | High Prevalence of Lower Limb Atherosclerosis is Linked with the Gut-Liver-Axis in Patients with Primary Biliary Cholangitis |
|
Liver Int. 2022 Oct 26. doi: 10.1111/liv.15463. Online ahead of print.
Francesca Romana Ponziani 1 2, Antonio Nesci 3, Camilla Caputo 1, Lucia Salvatore 1, Anna Picca 4, Federica Del Chierico 5, Francesco Paroni Sterbini 6, Emanuele Marzetti 4, Angela Di Giorgio 3, Luca Santoro 3, Lorenza Putignani 5 7, Antonio Gasbarrini 1 2, Angelo Santoliquido # 3 2, Maurizio Pompili # 1 2
|
|
|
|
|
53. | UK-wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis |
|
Clin Gastroenterol Hepatol. 2022 Aug 9;S1542-3565(22)00738-8.doi: 10.1016/j.cgh.2022.07.038. Online ahead of print.
Nadir Abbas 1, Emma L Culver 2, Douglas Thorburn 3, Neil Halliday 3, Hannah Crothers 4, Jessica K Dyson 5, April Phaw 5, Richard Aspinall 6, Salim I Khakoo 7, Yiannis Kallis 8, Belinda Smith 9, Imran Patanwala 10, Anne McCune 11, Chenchu R Chimakurthi 12, Vinod Hegade 12, Michael Orrell 2, Rebecca Jones 12, George Mells 13, Colette Thain 14, Robert-Mitchell Thain 14, David Jones 5, Gideon Hirschfield 15, Palak J Trivedi 16
|
|
|
54. | Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid |
|
Liver Int. 2022 Nov;42(11):2453-2465. doi: 10.1111/liv.15386. Epub 2022 Aug 23.
Antonio De Vincentis 1, Daphne D'Amato 2, Laura Cristoferi 3, Alessio Gerussi 3, Federica Malinverno 3, Ana Lleo 4, Francesca Colapietro 4, Fabio Marra 5, Andrea Galli 6, Cecilia Fiorini 6, Barbara Coco 7, Maurizia Brunetto 7, Grazia Anna Niro 8, Rosa Cotugno 8, Carlo Saitta 9, Raffaele Cozzolongo 10, Francesco Losito 10, Edoardo Giovanni Giannini 11, Sara Labanca 11, Marco Marzioni 12, Giulia Marconi 12, Anna Morgando 2, Rinaldo Pellicano 2, Ester Vanni 2, Nora Cazzagon 13, Annarosa Floreani 13, Luchino Chessa 14, Olivia Morelli 15, Luigi Muratori 16, Adriano Pellicelli 17, Maurizio Pompili 18, Francesca Ponziani 18, Annalisa Tortora 18, Floriano Rosina 19, Maurizio Russello 20, Mariarita Cannavò 20, Loredana Simone 21, Silvia Storato 22, Mauro Viganò 23, Ludovico Abenavoli 24, Maria D'Antò 25, Elisabetta De Gasperi 26, Marco Distefano 27, Gaetano Scifo 27, Teresa Zolfino 28, Vincenza Calvaruso 29, Giuseppe Cuccorese 30, Valeria Pace Palitti 31, Rodolfo Sacco 32, Gaetano Bertino 33, Evelise Frazzetto 33, Domenico Alvaro 34, Giacomo Mulinacci 3, Andrea Palermo 3, Miki Scaravaglio 3, Francesca Terracciani 1, Giovanni Galati 1, Vincenzo Ronca 3, Massimo Zuin 35 36, Ernesto Claar 37, Antonio Izzi 38, Antonio Picardi 1, Pietro Invernizzi 3, Umberto Vespasiani-Gentilucci 1, Marco Carbone 3, on behalf of the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) PBC Study Group and, the Italian PBC Registry
|
|
|
55. | Optimization of Laboratory Diagnostics of Primary Biliary Cholangitis: When Solid-Phase Assays and Immunofluorescence Combine |
|
Clin Med. 2022 Sep 5;11(17):5238. doi: 10.3390/jcm11175238.
Federica Gaiani 1 2, Roberta Minerba 3, Alessandra Picanza 3, Annalisa Russo 3, Alessandra Melegari 4, Elena De Santis 4, Tommaso Trenti 5, Lucia Belloni 6, Silvia Peveri 7, Rosalia Aloe 3, Carlo Ferrari 1 8, Luigi Laghi 1 2, Gian Luigi de'Angelis 1 2, Chiara Bonaguri 3
|
|
|
56. | Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma |
|
Dig Liver Dis. 2022 Sep;54(9):1215-1221. doi: 10.1016/j.dld.2022.03.002. Epub 2022 Mar 27.
Edoardo G Giannini 1, Giulia Pieri 2, Sara Labanca 2, Maria Corina Plaz Torres 2, Antonio Gasbarrini 3, Elisabetta Biasini 4, Claudia Campani 5, Nora Cazzagon 6, Francesco Giuseppe Foschi 7, Andrea Mega 8, Alberto Masotto 9, Giovanni Raimondo 10, Gian Ludovico Rapaccini 11, Rodolfo Sacco 12, Eugenio Caturelli 13, Maria Guarino 14, Francesco Tovoli 15, Gianpaolo Vidili 16, Maurizia Rossana Brunetto 17, Gerardo Nardone 18, Gianluca Svegliati-Baroni 19, Donatella Magalotti 20, Francesco Azzaroli 21, Giuseppe Cabibbo 22, Maria Di Marco 23, Angelo Sangiovanni 24, Franco Trevisani 25, Italian Liver Cancer (ITA.LI.CA) Study Group
|
|
|
57. | Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis |
|
Am J Gastroenterol. 2022 Sep 1. doi: 10.14309/ajg.0000000000001985. Online ahead of print.
Julian Hercun 1, Mazen Noureddin 1, Nabil Noureddin 1, Jason Eccleston 1, Daniel Woolridge 1, T Jake Liang 1, Michele Tana 1, David E Kleiner 2, Gracia Viana Rodriguez 1, Christopher Koh 1, Jay H Hoofnagle 1, Theo Heller 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65. | Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis |
|
J Hepatol. 2022 Jun 28;S0168-8278(22)00411-1. doi: 10.1016/j.jhep.2022.06.017.Online ahead of print.
Christophe Corpechot 1, Fabrice Carrat 2, Farid Gaouar 3, Frederic Chau 2, Gideon Hirschfield 4, Aliya Gulamhusein 4, Aldo J Montano-Loza 5, Ellina Lytvyak 5, Christoph Schramm 6, Albert Pares 7, Ignasi Olivas 7, John E Eaton 8, Karim T Osman 8, George Dalekos 9, Nikolaos Gatselis 9, Frederik Nevens 10, Nora Cazzagon 11, Alessandra Zago 11, Francesco Paolo Russo 11, Nadir Abbas 12, Palak Trivedi 12, Douglas Thorburn 13, Francesca Saffioti 13, Laszlo Barkai 13, Davide Roccarina 13, Vicenza Calvaruso 14, Anna Fichera 14, Adele Delamarre 15, Esli Medina-Morales 16, Alan Bonder 16, Vilas Patwardhan 16, Cristina Rigamonti 17, Marco Carbone 18, Pietro Invernizzi 18, Laura Cristoferi 18, Adriaan van der Meer 19, Rozanne de Veer 19, Ehud Zigmond 20, Eyal Yehezkel 20, Andreas E Kremer 21, Ansgar Deibel 21, Jerome Dumortier 22, Tony Bruns 23, Karsten Große 23, Georges-Philippe Pageaux 24, Aaron Wetten 25, Jessica Dyson 25, David Jones 25, Olivier Chazouilleres 3, Bettina Hansen 4, Victor de Lédinghen 15, Global & ERN Rare-Liver PBC Study Groups
|
|
|
66. | Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis |
|
Dig Dis Sci. 2022 Jun 15. doi: 10.1007/s10620-022-07581-x. Online ahead of print.
Marlyn J Mayo 1, Elizabeth Carey 2, Helen T Smith 3, Andrea R Mospan 4, Megan McLaughlin 5, April Thompson 6, Heather L Morris 4, Robert Sandefur 4, W Ray Kim 7, Christopher Bowlus 8, TARGET-PBC Investigators; Cynthia Levy 9
|
|
|
|
|
68. | The National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection System |
|
Cureus. 2022 Jun 2;14(6):e25609. doi: 10.7759/cureus.25609. eCollection 2022 Jun.
Laura Burke 1, Steve Flack 2, Rebecca Jones 3, Richard J Aspinall 4, Douglas Thorburn 5, David E Jones 6, Conor Braniff 7, Collette Thain 8, Andrew Yeoman 9, Joanna A Leithead 10, Palak J Trivedi 11, George Mells 2, Laith Alrubaiy 12
|
|
|
|
|
|
|
71. | The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study |
|
EBioMedicine. 2022 May 21;80:104068. doi: 10.1016/j.ebiom.2022.104068. Online ahead of print.
David E J Jones 1, Aaron Wetten 2, Ben Barron-Millar 3, Laura Ogle 3, George Mells 4, Steven Flack 4, Richard Sandford 4, John Kirby 3, Jeremy Palmer 3, Sophie Brotherston 3, Laura Jopson 3, John Brain 3, Graham R Smith 5, Steve Rushton 6, Rebecca Jones 7, Simon Rushbrook 8, Douglas Thorburn 9, Stephen D Ryder 10, Gideon Hirschfield 11, UK-PBC Research Consortium; Jessica K Dyson 2
|
|
|
72. | High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases |
|
Hepatol Commun. 2022 May;6(5):965-979. doi: 10.1002/hep4.1871. Epub 2021 Nov 26.
Douglas I Walker # 1, Brian D Juran # 2, Angela C Cheung 3, Erik M Schlicht 2, Yongliang Liang 4, Megan Niedzwiecki 1, Nicholas F LaRusso 2, Gregory J Gores 2, Dean P Jones 4, Gary W Miller 5, Konstantinos N Lazaridis 2
|
|
|
|
|
|
|
75. | Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis |
|
Sci Rep. 2022 Feb 22;12(1):3027. doi: 10.1038/s41598-022-06809-0.
Davide Povero # 1, Masahiko Tameda # 2, Akiko Eguchi 2, Wenhua Ren 3, Jihoon Kim 4, Robert Myers 5, Zachary D Goodman 6, Stephen A Harrison 7, Arun J Sanyal 8, Jaime Bosch 9 10, Lucila Ohno-Machado 4, Ariel E Feldstein 11
|
|
|
|
|
|
|
78. | A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis |
|
J Hepatol. 2022 Mar 30;S0168-8278(22)00187-8. doi: 10.1016/j.jhep.2022.02.033.Online ahead of print.
Christopher L Bowlus 1, Michael R Galambos 2, Richard J Aspinall 3, Gideon M Hirschfield 4, David E J Jones 5, Yvonne Dörffel 6, Stuart C Gordon 7, Stephen A Harrison 8, Andreas E Kremer 9, Marlyn J Mayo 10, Paul J Thuluvath 11, Cynthia Levy 12, Mark G Swain 13, Guy W Neff 14, David A Sheridan 15, Carmen M Stanca 16, Christoph P Berg 17, Aparna Goel 18, Mitchell L Shiffman 19, John M Vierling 20, Pol Boudes 21, Alexandra Steinberg 21, Yun-Jung Choi 21, Charles A McWherter 21
|
|
|
|
|
|
|
|
|
|
|
83. | Ethnicity, disease severity and survival in Canadian patients with Primary Biliary Cholangitis |
|
Hepatology. 2022 Feb 26. doi: 10.1002/hep.32426. Online ahead of print.
Surain B Roberts 1 2, Gideon M Hirschfield 1 2, Lawrence J Worobetz 3, Catherine Vincent 4, Jennifer A Flemming 5, Angela Cheung 6, Karim Qumosani 7, Mark Swain 8, Dusanka Grbic 9, Hin Hin Ko 10, Kevork Peltekian 11, Nazia Selzner 12, Lusine Abrahamyan 2 12, Bishoi Aziz 13, Ellina Lytvyak 13, Kattleya Tirona 1, Aliya F Gulamhusein 1 2, Harry LA Janssen 1, Aldo J Montano-Loza 13, Andrew L Mason 13, Bettina E Hansen 1 2, Canadian Network for Autoimmune Liver disease (CaNAL)
|
|
|
|
|
|
|
|
|
|
|
88. | Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis |
|
Clin Med. 2022 Jan 28;11(3):681. doi: 10.3390/jcm11030681.
Anne-Christin Beatrice Wilde 1, Lena Maria Greverath 1, Lara Marleen Steinhagen 1, Nina Wald de Chamorro 1, Elise Leicht 1, Janett Fischer 2, Toni Herta 2, Thomas Berg 2, Beate Preuss 3, Reinhild Klein 3, Frank Tacke 1, Tobias Müller 1
|
|
|
89. | Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation |
|
Haematologica. 2021 Sep 1;106(9):2374-2383. doi: 10.3324/haematol.2019.245407.
Pierre-Edouard Debureaux 1, Pierre Bourrier 2, Pierre-Emmanuel Rautou 3, Anne-Marie Zagdanski 2, Morgane De Boutiny 2, Simona Pagliuca 1, Aurélien Sutra Del Galy 1, Marie Robin 1, Régis Peffault de Latour 1, Aurélie Plessier 4, Flore Sicre de Fontbrune 1, Aliénor Xhaard 1, Pedro Henrique de Lima Prata 1, Dominique Valla 3, Gérard Socié 1, David Michonneau 1
|
|
|
|
|
91. | Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium |
|
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e197-e205.doi: 10.1097/MEG.0000000000002011.
Alexandre Pariente 1, Olivier Chazouilleres 2, Xavier Causse 3, Bertrand Hanslik 4, Jean-Pierre Arpurt 5, Jean Henrion 6, Isabelle Rosa 7, Christophe Renou 8, Armand Garioud 9, Christophe Corpechot 2, DESCRIPT and DESCRIPT Study Groups
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100. | Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis |
|
Hepatology. 2021 Aug;74(2):879-891. doi: 10.1002/hep.31776. Epub 2021 May 26.
Binu V John 1, Gabriella Aitcheson 2, Kaley B Schwartz 1, Nidah S Khakoo 2, Bassam Dahman 3, Yangyang Deng 3, David Goldberg 4, Paul Martin 4, Tamar H Taddei 5 6, Cynthia Levy 4, David E Kaplan 7 8
|
|
|
|
|
102. | Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis |
|
Liver Int. 2021 Aug 17. doi: 10.1111/liv.15039. Online ahead of print.
Andreas E Kremer 1 2, Marlyn J Mayo 3, Gideon Hirschfield 4, Cynthia Levy 5, Christopher L Bowlus 6, David E Jones 7, Alexandra Steinberg 8, Charles A McWherter 8, Yun-Jung Choi 8
|
|
|
|
|
104. | The genetic architecture of primary biliary cholangitis |
|
Eur J Med Genet. 2021 Jul 23;64(9):104292. doi: 10.1016/j.ejmg.2021.104292.Online ahead of print.
Alessio Gerussi 1, Marco Carbone 2, Cristophe Corpechot 3, Christoph Schramm 4, Rosanna Asselta 5, Pietro Invernizzi 6
|
|
|
|
|
|
|
|
|
108. | Baricitinib and primary biliary cholangitis |
|
J Transl Autoimmun. 2021 Jun 1;4:100107. doi: 10.1016/j.jtauto.2021.100107. eCollection 2021.
Stuart C Gordon 1 2, Sheri Trudeau 3, Arie Regev 4, Jonathan M Uhas 1, Sujatro Chakladar 4, Ana Pinto-Correia 4, Klaus Gottlieb 4, Doug Schlichting 4
|
|
|
109. | Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study |
|
Am J Gastroenterol. 2021 Jun 23. doi: 10.14309/ajg.0000000000001343. Online ahead of print.
Anna Reig 1 2, Carmen Álvarez-Navascués 3, Mercedes Vergara 2 4, Elena Gómez-Domínguez 5, Adolfo Gallego-Moya 6, Indhira M Pérez-Medrano 7, Emilio Fábrega 8, Manuel Hernández-Guerra 9, Marina Berenguer 2 10 11, Pamela Estevez 12, Ana Arencibia 13, Rosa M Morillas 2 14, Diana Horta 15, Agustín Albillos 2 16, Marta Casado 17, Gema De la Cruz 18, Eva Fernandez-Bonilla 19, Esther Molina 20, Lander Hijona 21, Moises Diago 22, Conrado M Fernández-Rodriguez 23, Jesús M González-Santiago 24, Margarita Sala 2 25, Judith Gómez-Camarero 26, Manuel Romero-Gomez 2 27, Francisco Suárez 28, Victor Vargas 2 29, Carlos Ferre-Aracil 30, Raúl J Andrade 2 31, Nadia Chahri 32, Albert Parés 1 2
Affi
|
|
|
110. | The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis |
|
Hepatology. 2021 Jun 15. doi: 10.1002/hep.32011. Online ahead of print.
Ben Barron-Millar 1, Laura Ogle 1, George Mells 2, Steven Flack 2, Jonathan Badrock 2, Richard Sandford 2, John Kirby 1, Jeremy Palmer 1, Laura Jopson 1, John Brain 1, Graham R Smith 3, Steve Rushton 4, Vinod S Hegade 5, Rebecca Jones 5, Simon Rushbrook 6, Douglas Thorburn 7, Steve Ryder 8, Gideon Hirschfield 9 10, UK-PBC Research Consortium; Jessica K Dyson 1 11, David Jones 1 11
|
|
|
111. | An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs |
|
Heather J Cordell 1, James J Fryett 1, Kazuko Ueno 2, Rebecca Darlay 1, Yoshihiro Aiba 3, Yuki Hitomi 4, Minae Kawashima 4, Nao Nishida 4, Seik-Soon Khor 2, Olivier Gervais 5, Yosuke Kawai 2, Masao Nagasaki 5, Katsushi Tokunaga 2, Ruqi Tang 6, Yongyong Shi 7, Zhiqiang Li 7, Brian D Juran 8, Elizabeth J Atkinson 9, Alessio Gerussi 10, Marco Carbone 10, Rosanna Asselta 11, Angela Cheung 8, Mariza de Andrade 9, Aris Baras 12, Julie Horowitz 12, Manuel A R Ferreira 12, Dylan Sun 12, David E Jones 13, Steven Flack 14, Ann Spicer 14, Victoria L Mulcahy 14, Jinyoung Byan 15, Younghun Han 15, Richard N Sandford 14, Konstantinos N Lazaridis 8, Christopher I Amos 15, Gideon M Hirschfield 16, Michael F Seldin 17, Pietro Invernizzi 10, Katherine A Siminovitch 18, Xiong Ma 6, Minoru Nakamura 3, George F Mells 19, Canadian PBC Consortium, Chinese PBC Consortium, Italian PBC Study Group, Japan-PBC-GWAS Consortium, US PBC Consortium, and UK-PBC Consortium
|
|
|
|
|
|
|
|
|
115. | Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis |
|
Am J Gastroenterol. 2021 May 13. doi: 10.14309/ajg.0000000000001280. Online ahead of print.
Binu V John 1, Nidah S Khakoo, Kaley B Schwartz, Gabriella Aitchenson, Cynthia Levy, Bassam Dahman, Yangyang Deng, David S Goldberg, Paul Martin, David E Kaplan, Tamar H Taddei
|
|
|
|
|
117. | A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis |
|
Am J Gastroenterol. 2021 May 4. doi: 10.14309/ajg.0000000000001285. Online ahead of print.
Jorn C Goet 1, Carla F Murillo Perez, Maren H Harms, Annarosa Floreani, Nora Cazzagon, Tony Bruns, Florian Prechter, George N Dalekos, Xavier Verhelst, Nikolaos K Gatselis, Keith D Lindor, Willem J Lammers, Aliya Gulamhusein, Anna Reig, Marco Carbone, Frederik Nevens, Gideon M Hirschfield, Adriaan J van der Meer, Henk R van Buuren, Bettina E Hansen, Albert Parés, GLOBAL PBC Study Group
|
|
|
|
|
|
|
|
|
|
|
|
|
123. | Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis |
|
Aliment Pharmacol Ther. 2021 Mar 25. doi: 10.1111/apt.16336. Online ahead of print.
Pierre-Antoine Soret 1, Laurent Lam 1, Fabrice Carrat 1, Lena Smets 2, Thomas Berg 3, Marco Carbone 4, Pietro Invernizzi 4, Vincent Leroy 5, Palak Trivedi 6, Nora Cazzagon 7, Christina Weiler-Normann 8, Laurent Alric 9, Isabelle Rosa-Hezode 10, Alexandra Heurgué 11, Jean-Paul Cervoni 12, Jérôme Dumortier 13, Pascal Potier 14, Olivier Roux 15, Christine Silvain 16, Christophe Bureau 9, Rodolphe Anty 17, Dominique Larrey 18, Cynthia Levy 19, Albert Pares 20, Christoph Schramm 8, Frederik Nevens 2, Olivier Chazouillères 1, Christophe Corpechot 1
|
|
|
124. | Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis |
|
Aliment Pharmacol Ther. 2021 Mar 25. doi: 10.1111/apt.16336. Online ahead of print.
Pierre-Antoine Soret 1, Laurent Lam 1, Fabrice Carrat 1, Lena Smets 2, Thomas Berg 3, Marco Carbone 4, Pietro Invernizzi 4, Vincent Leroy 5, Palak Trivedi 6, Nora Cazzagon 7, Christina Weiler-Normann 8, Laurent Alric 9, Isabelle Rosa-Hezode 10, Alexandra Heurgué 11, Jean-Paul Cervoni 12, Jérôme Dumortier 13, Pascal Potier 14, Olivier Roux 15, Christine Silvain 16, Christophe Bureau 9, Rodolphe Anty 17, Dominique Larrey 18, Cynthia Levy 19, Albert Pares 20, Christoph Schramm 8, Frederik Nevens 2, Olivier Chazouillères 1, Christophe Corpechot 1
|
|
|
|
|
|
|
127. | Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach |
|
Hepatology. 2021 Mar 16. doi: 10.1002/hep.31810. Online ahead of print.
Laura Cristoferi 1 2 3, Vincenza Calvaruso 4, Diletta Overi 5, Mauro Viganò 6, Cristina Rigamonti 7, Elisabetta Degasperi 8, Vincenzo Cardinale 9, Sara Labanca 10, Nicola Zucchini 11, Anna Fichera 4, Vito Di Marco 4, Monica Leutner 12, Rosanna Venere 13, Antonino Picciotto 10, Martina Lucà 1 2, Giacomo Mulinacci 1 2, Andrea Palermo 1 2, Alessio Gerussi 1 2, Daphne D'Amato 1 2, Sarah Elisabeth O'Donnell 1 2, Federica Cerini 6, Carla De Benedittis 7, Federica Malinverno 1 2, Vincenzo Ronca 1 2, Clara Mancuso 1 2, Nora Cazzagon 14, Antonio Ciaccio 1 2, Donatella Barisani 1, Marco Marzioni 15, Annarosa Floreani 16 17, Domenico Alvaro 9, Eugenio Gaudio 5, Pietro Invernizzi 1 2, Guido Carpino 18, Alessandra Nardi 19, Marco Carbone 1 2, behalf of the Italian PBC Registry
|
|
|
128. | Real-world experience with obeticholic acid in patients with primary biliary cholangitis |
|
JHEP Rep. 2021 Jan 27;3(2):100248. doi: 10.1016/j.jhepr.2021.100248. eCollection 2021 Apr.
Daphne D'Amato 1, Antonio De Vincentis 2, Federica Malinverno 1, Mauro Viganò 3, Domenico Alvaro 4, Maurizio Pompili 5, Antonino Picciotto 6, Valeria Pace Palitti 7, Maurizio Russello 8, Silvia Storato 9, Marie Graciella Pigozzi 10, Vincenza Calvaruso 11, Elisabetta De Gasperi 12, Ana Lleo 13, Antonino Castellaneta 14, Adriano Pellicelli 15, Nora Cazzagon 16, Annarosa Floreani 16, Luigi Muratori 17, Stefano Fagiuoli 18, Grazia Anna Niro 19, Valentina Feletti 20, Raffaele Cozzolongo 21, Natalia Terreni 22, Marco Marzioni 23, Rinaldo Pellicano 24, Pietro Pozzoni 25, Leonardo Baiocchi 26, Luchino Chessa 27, Floriano Rosina 28, Gaetano Bertino 29, Maria Vinci 30, Anna Morgando 24, Ester Vanni 24, Gaetano Scifo 31, Rodolfo Sacco 32, Maria D'Antò 33, Valentina Bellia 34, Roberto Boldizzoni 35, Silvia Casella 36, Barbara Omazzi 37, Guido Poggi 38, Laura Cristoferi 1, Alessio Gerussi 1, Vincenzo Ronca 1, Rosanna Venere 4, Francesca Ponziani 5, Maria Cannavò 8, Alessandro Mussetto 20, Rosanna Fontana 19, Francesco Losito 21, Evelise Frazzetto 29, Marco Distefano 31, Francesca Colapietro 13, Sara Labanca 6, Giulia Marconi 23, Giuseppe Grassi 26, Giovanni Galati 2, Sarah Elizabeth O'Donnell 1, Clara Mancuso 1, Giacomo Mulinacci 1, Andrea Palermo 1, Ernesto Claar 39, Antonio Izzi 40, Antonio Picardi 2, Pietro Invernizzi 1, Marco Carbone 1, Umberto Vespasiani-Gentilucci 2, Italian PBC Registry and the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) PBC Study Group
|
|
|
|
|
130. | X chromosome contribution to the genetic architecture of primary biliary cholangitis |
|
Gastroenterology. 2021 Mar 3;S0016-5085(21)00466-2. doi: 10.1053/j.gastro.2021.02.061.Online ahead of print.
Gastroenterology. 2021 Mar 3;S0016-5085(21)00466-2. doi: 10.1053/j.gastro.2021.02.061.Online ahead of print.
Rosanna Asselta 1, Elvezia Maria Paraboschi 1, Alessio Gerussi 2, Heather J Cordell 3, George F Mells 4, Richard N Sandford 4, David E Jones 5, Minoru Nakamura 6, Kazuko Ueno 7, Yuki Hitomi 8, Minae Kawashima 8, Nao Nishida 8, Katsushi Tokunaga 9, Masao Nagasaki 10, Atsushi Tanaka 11, Ruqi Tang 12, Zhiqiang Li 13, Yongyong Shi 13, Xiangdong Liu 14, Ma Xiong 12, Gideon Hirschfield 15, Katherine A Siminovitch 16, Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium; Japan PBC-GWAS Consortium; Marco Carbone 2, Giulia Cardamone 1, Stefano Duga 1, M Eric Gershwin 17, Michael F Seldin 17, Pietro Invernizzi 18
|
|
|
131. | Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison |
|
J Transl Autoimmun. 2021 Jan 6;4:100081. doi: 10.1016/j.jtauto.2021.100081. eCollection 2021.
Lorenzo Montali 1, Andrea Gragnano 1, Massimo Miglioretti 1, Alessandra Frigerio 1, Luca Vecchio 1, Alessio Gerussi 2 3, Laura Cristoferi 2 3, Vincenzo Ronca 2 3, Daphne D'Amato 2 3, Sarah Elizabeth O'Donnell 2 3, Clara Mancuso 2 3, Martina Lucà 2 3, Minami Yagi 4, Anna Reig 5, Laura Jopson 6, Sesé Pilar 5, Dave Jones 6, Albert Pares 5, George Mells 7, Atsushi Tanaka 4, Marco Carbone 2 3, Pietro Invernizzi 2 3
|
|
|
|
|
|
|
134. | Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis |
|
Clin Gastroenterol Hepatol. 2020 Aug 7;S1542-3565(20)31083-1.doi: 10.1016/j.cgh.2020.08.006. Online ahead of print.
Alessio Gerussi 1, Davide Paolo Bernasconi 2, Sarah Elisabeth O'Donnell 1, Willem J Lammers 3, Henk Van Buuren 3, Gideon Hirschfield 4, Harry Janssen 4, Christophe Corpechot 5, Anna Reig 6, Albert Pares 6, Pier Maria Battezzati 7, Massimo Giovanni Zuin 7, Nora Cazzagon 8, Annarosa Floreani 9, Frederik Nevens 10, Nikolaos Gatselis 11, George Dalekos 11, Marlyn J Mayo 12, Douglas Thorburn 13, Tony Bruns 14, Andrew L Mason 15, Xavier Verhelst 16, Kris Kowdley 17, Adriaan van der Meer 3, Grazia Anna Niro 18, Benedetta Terziroli Beretta-Piccoli 19, Marco Marzioni 20, Luca Saverio Belli 21, Fabio Marra 22, Maria Grazia Valsecchi 2, Keith D Lindor 23, Pietro Invernizzi 1, Bettina E Hansen 24, Marco Carbone 25, Italian PBC Study Group and the GLOBAL PBC Study Group
|
|
|
135. | Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool |
|
Eur J Gastroenterol Hepatol. 2020 Dec 14. doi: 10.1097/MEG.0000000000002029.Online ahead of print.
Carla F Murillo Perez 1 2, Aliya Gulamhusein 1, Marco Carbone 3 4, Palak J Trivedi 5, Adriaan J van der Meer 2, Christophe Corpechot 6, Pier Maria Battezzati 7, Willem J Lammers 2, Nora Cazzagon 4 8, Annarosa Floreani 4 8, Albert Parés 9, Frederik Nevens 10, Ana Lleo 11, Marlyn J Mayo 12, Kris V Kowdley 13, Cyriel Y Ponsioen 14, George N Dalekos 15, Nikolaos K Gatselis 15, Douglas Thorburn 16, Andrew L Mason 17, Harry Janssen 1, Xavier Verhelst 4 18, Tony Bruns 19, Keith D Lindor 20, Olivier Chazouillères 6, Pietro Invernizzi 3 4, Bettina E Hansen 1 21, Gideon M Hirschfield 1, GLOBAL PBC Study Group
|
|
|
|
|
|
|
|
|
139. | A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA |
|
J Hepatol. 2021 Jan 20;S0168-8278(21)00022-2. doi: 10.1016/j.jhep.2021.01.013.Online ahead of print.
Jörn M Schattenberg 1, Albert Pares 2, Kris V Kowdley 3, Michael A Heneghan 4, Stephen Caldwell 5, Daniel Pratt 6, Alan Bonder 7, Gideon M Hirschfield 8, Cynthia Levy 9, John Vierling 10, David Jones 11, Anne Tailleux 12, Bart Staels 12, Sophie Megnien 13, Remy Hanf 13, David Magrez 13, Pascal Birman 13, Velimir Luketic 14
|
|
|
|
|
|
|
142. | Primary biliary cholangitis |
|
Lancet. 2020 Dec 12;396(10266):1915-1926. doi: 10.1016/S0140-6736(20)31607-X.
Ana Lleo 1, Giu-Qiang Wang 2, Merrill Eric Gershwin 3, Gideon M Hirschfield 4
|
|
|
|
|
|
|
|
|
146. | Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial |
|
Gastroenterology. 2020 Oct 5;S0016-5085(20)35226-4. doi:10.1053/j.gastro.2020.10.001.Online ahead of print.
Elsemieke de Vries 1, Ruth Bolier 1, Jorn Goet 2, Albert Parés 3, Jef Verbeek 4, Marleen de Vree 5, Joost Drenth 6, Karel van Erpecum 7, Karin van Nieuwkerk 8, Frans van der Heide 5, Nahid Mostafavi 1, Jeltje Helder 1, Cyriel Ponsioen 1, Ronald Oude Elferink 1, Henk van Buuren 2, Ulrich Beuers 9, Netherlands Association for the Study of the Liver - Cholestasis Working Group
|
|
|
|
|
148. | A placebo-controlled randomised trial of budesonide for primary biliary cholangitis following an insufficient response to UDCA |
|
J Hepatol. 2020 Sep 17;S0168-8278(20)33623-0. doi: 10.1016/j.jhep.2020.09.011.Online ahead of print.
G M Hirschfield 1, U Beuers 2, L Kupcinskas 3, P Ott 4, A Bergquist 5, M Färkkilä 6, M P Manns 7, A Parés 8, U Spengler 9, M Stiess 10, R Greinwald 10, M Pröls 10, D Wendum 11, U Drebber 12, R Poupon 13
|
|
|
149. | Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis |
|
J Clin Gastroenterol. 2020 Sep 23. doi: 10.1097/MCG.0000000000001433. Online ahead of print.
Karim T Osman 1, Daniel B Maselli 1, Ilkay S Idilman 2, Daniel J Rowan 3, Jason K Viehman 4, William S Harmsen 4, Denise M Harnois 5, Elizabeth J Carey 6, Andrea A Gossard 1, Nicholas F LaRusso 1, Keith D Lindor 6, Sudhakar K Venkatesh 2, John E Eaton 1
|
|
|
|
|
|
|
152. | Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis |
|
Liver Int. 2020 Aug 25. doi: 10.1111/liv.14645. Online ahead of print.
Emma L Culver 1, Helen K Bungay 2, Margaret Betts 2, Colm Forde 2 3, Otto Buchel 4, Charis Manganis 1, Bryan F Warren 5, Jr Fraser Cummings 1 6, Satish Keshav 1, Simon P L Travis 1, Roger W Chapman 1
|
|
|
|
|
|
|
|
|
|
|
|
|
158. | Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom |
|
Clin Gastroenterol Hepatol. 2020 Jun 17;S1542-3565(20)30836-3.doi: 10.1016/j.cgh.2020.06.025. Online ahead of print.
Stephen Rice 1, Viviana Albani 2, Dimitrios Minos 3, Gulnar Fattakhova 2, George F Mells 4, Marco Carbone 4, Steven Flack 4, Nikoletta Varvaropoulou 4, Jonathan Badrock 4, Ann Spicer 4, Richard N Sandford 4, Mark D F Shirley 5, Diarmuid Coughlan 2, Gideon Hirschfield 6, Simon D Taylor-Robinson 7, UK-PBC Consortium; Luke Vale 2, David E J Jones 8
|
|
|
159. | Risk Factors for Complications After Cholecystectomy for Common Bile Duct Stones: An EAST Multicenter Study |
|
Surgery. 2020 Jul;168(1):62-66. doi: 10.1016/j.surg.2020.04.011. Epub 2020 May 26.
Brett M Tracy 1, Cameron W Paterson 2, Denise M Torres 3, Katelyn Young 3, Beth R Hochman 4, Martin D Zielinski 5, Sigrid K Burruss 6, Michelle B Mulder 7, Daniel Dante Yeh 7, Rondi B Gelbard 2, EAST Retained Common Bile Duct Stones Study Group
- EAST Retained Common Bile Duct Stones Study Group:
Beth Hochman, Natasha Coleman, Anna Goldenberg-Sandau, Jennifer Schweinsburg, Rondi Gelbard, Cameron Paterson, Brett Tracy, Rondi Gelbard, Cameron Paterson, Brett Tracy, Katelyn Young, Denise Torres, David Morris, Ashley Boyer, Sigrid Burruss, Xian Luo-Owen, Daniel Cullinane, Laura Cullinane, April Mendoza, Apostolos Gaitanidis, Martin Zielinski, Maraya Camazine, Shaneeta Johnson, Michelle Mulder, Rishi Rattan, D Dante Yeh, Jonathan Saxe, Daniel Kinstedt, Amanda Celii, Kiran Venincasa
|
|
|
|
|
|
|
162. | Pregnancy Outcomes in Women With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Retrospective Cohort Study |
|
BJOG. 2020 Jun;127(7):876-884. doi: 10.1111/1471-0528.16119. Epub 2020 Mar 8.
M Cauldwell 1, F L Mackie 2, P J Steer 1, M A Henehghan 3, J H Baalman 4, J Brennand 5, T Johnston 2, S Dockree 6, C Hedley 7, S Jarvis 8, S Khan 9, F M McAuliffe 4, L Mackillop 6, L Penna 7, B Smith 10, P Trivedi 9, S Verma 11 12, R Westbrook 13, S Winifield 14, C Williamson 15
|
|
|
|
|
164. | Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase |
|
Am J Gastroenterol. 2020 Feb 20. doi: 10.14309/ajg.0000000000000557. Online ahead of print.
Carla F Murillo Perez 1 2, Maren H Harms 2, Keith D Lindor 3, Henk R van Buuren 2, Gideon M Hirschfield 1, Christophe Corpechot 4, Adriaan J van der Meer 2, Jordan J Feld 1, Aliya Gulamhusein 1, Willem J Lammers 2, Cyriel Y Ponsioen 5, Marco Carbone 6, Andrew L Mason 7, Marlyn J Mayo 8, Pietro Invernizzi 6, Pier Maria Battezzati 9, Annarosa Floreani 10, Ana Lleo 11, Frederik Nevens 12, Kris V Kowdley 13, Tony Bruns 14 15, George N Dalekos 16, Nikolaos K Gatselis 16, Douglas Thorburn 17, Palak J Trivedi 18, Xavier Verhelst 19, Albert Parés 20, Harry L A Janssen 1, Bettina E Hansen 1 21, GLOBAL PBC Study Group
|
|
|
|
|
166. | Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis |
|
Am J Gastroenterol. 2020 Feb;115(2):262-270. doi: 10.14309/ajg.0000000000000512.
Stuart C Gordon 1, Kuan-Han Hank Wu 2, Keith Lindor 3, Christopher L Bowlus 4, Carla V Rodriguez 5 6, Heather Anderson 7, Joseph A Boscarino 8, Sheri Trudeau 2, Loralee B Rupp 9, Irina V Haller 10, Robert J Romanelli 11, Jeffrey J VanWormer 12, Mark A Schmidt 13, Yihe G Daida 14, Amandeep Sahota 15, Jennifer Vincent 16, Talan Zhang 1, Jia Li 1, Mei Lu 1, FOLD Investigators
|
|
|
|
|
|
|
169. | Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom |
|
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1379-1387.e3. doi: 10.1016/j.cgh.2018.12.007.Epub 2018 Dec 14.
Vinod S Hegade 1, George F Mells 2, Holly Fisher 3, Stuart Kendrick 4, Julia DiBello 5, Kim Gilchrist 5, Graeme J Alexander 2, Gideon M Hirschfield 6, Richard N Sandford 7, David E J Jones 8, UK-PBC Consortium
|
|
|
170. | Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis |
|
Gastroenterol Hepatol. 2019 Sep;17(10):2076-2084.e2. doi: 10.1016/j.cgh.2018.12.028.Epub 2019 Jan 4.
Angela C Cheung 1, Willem J Lammers 2, Carla F Murillo Perez 3, Henk R van Buuren 2, Aliya Gulamhusein 3, Palak J Trivedi 4, Konstantinos N Lazaridis 1, Cyriel Y Ponsioen 5, Annarosa Floreani 6, Gideon M Hirschfield 3, Christophe Corpechot 7, Marlyn J Mayo 8, Pietro Invernizzi 9, Pier Maria Battezzati 10, Albert Parés 11, Frederik Nevens 12, Douglas Thorburn 13, Andrew L Mason 14, Marco Carbone 9, Kris V Kowdley 15, Tony Bruns 16, George N Dalekos 17, Nikolaos K Gatselis 17, Xavier Verhelst 18, Keith D Lindor 19, Ana Lleo 9, Raoul Poupon 7, Harry L A Janssen 3, Bettina E Hansen 20, Global PBC Study Group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
195. | Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease |
|
Jiang ZG1, Tapper EB1, Connelly MA2, Pimentel CM1, Feldbrügge L1, Kim M3, Krawczyk S3, Afdh Al N1, Robson SC1, Herman M3, Otvos JD2, Mukamal KJ4, Lai M1. Liver Int. 2016 Jan 27. doi: 10.1111/liv.13076. [Epub ahead of print] |
|
|
|
|
|
|
|
|
|
|
|
|
201. | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study |
|
Armstrong MJ1, Gaunt P2, Aithal GP3, Barton D4, Hull D4, Parker R1, Hazlehurst JM5, Guo K4; LEAN trial team, Abouda G6, Aldersley MA7, Stocken D8, Gough SC5, Tomlinson JW5, Brown RM9, Hübscher SG10, Newsome PN11. Lancet. 2015 Nov 19. pii: S0140-6736(15)00803-X. doi: 10.1016/S0140-6736(15)00803-X. [Epub ahead of print] |
|
|
|
|
|
|
|
|
205. | Non-alcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery |
|
Goossens N1, Hoshida Y2, Song WM3, Jung M4, Morel P4, Nakagawa S5, Zhang B3, Frossard JL6, Spahr L6, Friedman SL5, Negro F7, Rubbia-Brandt L8, Giostra E6. Clin Gastroenterol Hepatol. 2015 Oct 19. pii: S1542-3565(15)01406-8. doi: 10.1016/j.cgh.2015.10.010. [Epub ahead of print] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
216. | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability |
|
Luther J1, Garber JJ1, Khalili H1, Dave M2, Bale SS3, Jindal R3, Motola DL1, Luther S1, Bohr S3, Jeoung SW1, Deshpande V1, Singh G4, Turner JR4, Yarmush ML3, Chung RT1, Patel SJ3. Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232. |
|
|
|
|
|
|
|
|
220. | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability |
|
Luther J1, Garber JJ1, Khalili H1, Dave M2, Bale SS3, Jindal R3, Motola DL1, Luther S1, Bohr S3, Jeoung SW1, Deshpande V1, Singh G4, Turner JR4, Yarmush ML3, Chung RT1, Patel SJ3. Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
229. | Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH? |
|
Kohli R1, Myronovych A, Tan BK, Salazar-Gonzalez RM, Miles L, Zhang W, Oehrle M, Sandoval DA, Ryan KK, Seeley RJ, Setchell KD. Dig Dis. 2015;33(3):440-6. doi: 10.1159/000371699. Epub 2015 May 27. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|